Clarity Presentation -Bell Potter Healthcare Conference 2022
Filed with ASX · · 26 pages · English
Clarity Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from Clarity Pharmaceuticals
- 50% recruitment reached for Phase II prostate cancer trial
- Corporate Presentation - Wilsons Drug and Device Conference
- 50% recruitment milestone reached for prostate cancer trial
- First patient treated in therapeutic prostate cancer trial
- First participant imaged in Phase II SAR-Bombesin trial
Later from Clarity Pharmaceuticals
- IND approval from the FDA for theranostic SAR-Bombesin trial
- Chairmans Address to Shareholders
- Managing Directors Presentation to AGM
- Positive topline results from SAR-bisPSMA diagnostic trial
- Diagnostic prostate cancer trial reaches recruitment target
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals